PlainDoctor

2026 NPPES data Hematology & Oncology Physician NPI 1881896157 M.D.
Verify on CMS →

Megan Baumgart, M.D.

Hematology & Oncology Physician in Rochester, New York.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
359
Medicare Part D claims · 107 beneficiaries · Hematology & Oncology Physician avg: 885
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
76.8/100
▼ 7 pts below national avg 83.5 · Above neutral
Verify NPI on CMS Methodology
Compiled from official public sources by the editorial process.

What the federal data shows

Megan Baumgart, M.D. reported a CMS MIPS final score of 76.8/100 - below the 83.5 national average - and filed 359 Medicare Part D claims in 2024.

76.8/100
MIPS score · -7 vs avg
359
Part D claims, 2024
86%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Megan Baumgart, M.D.

Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1881896157), first enumerated 05/31/2007.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 359 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    CMS quality reporting (MIPS)

    Reported a CMS MIPS final score of 76.8/100 in the Quality Payment Program — a federal quality measure, not a patient review.

    Source: CMS Quality Payment Program

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • State context

    State board disciplinary context

    New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Megan Baumgart, M.D.'s individual license status. Verify directly with the state medical board.

    Source: NYSBPMC annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1881896157 · Hematology & Oncology Physician

NPI-10 · ENUM-MID · TAX-MID · MIPS-BELOW · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH

  • NPI-10 1881896157
  • ENUM-MID 2007
  • TAX-MID 12K Hematology &
  • MIPS-BELOW 76.8/100
  • RX-LIGHT 359
  • BOOK-LIGHT 999 in New York
  • PHOTO-FINISH Srinivasu Chamarthy,… · ±0.0

MIPS final-score neighbourhood

Same-specialty nationwide peers by CMS final score, not geographic proximity

MIPS pts

What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).

Source CMS Quality Payment Program (MIPS) As of 2023

Megan Baumgart, M.D.'s MIPS score vs every measured U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.

77 ≥ 17th percentile 17% of 454,083 measured providers are in lower value bands

0–10: 8,684 measured providers (2%). Below this entry. 10–20: 3,008 measured providers (1%). Below this entry. 20–30: 3,069 measured providers (1%). Below this entry. 30–40: 2,746 measured providers (1%). Below this entry. 40–50: 2,928 measured providers (1%). Below this entry. 50–60: 5,882 measured providers (1%). Below this entry. 60–70: 13,906 measured providers (3%). Below this entry. 70–80: 94,570 measured providers (21%). This entry sits in this band. 80–90: 129,887 measured providers (29%). Above this entry. 90+: 189,403 measured providers (42%). Above this entry. This provider 0 100 every measured MIPS clinician, bucketed by value

Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Megan Baumgart, M.D. sits

This provider among hematology & oncology physician peers

Across the 4,019 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Megan Baumgart, M.D. writes more Part D claims than 28% of them and scores higher on MIPS quality than 18% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100024.148.372.496.6Part D claim volume, percentile in specialtyMIPS quality, percentilePoint, Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 7Point, Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 63Point, Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 40Point, Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 78Point, Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 23Point, Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 60Point, Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 80Point, Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 73Point, Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 25Point, Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 35Point, Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 57Point, Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 47Point, Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 30Point, Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 8Point, Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 75Point, Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 2Point, Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 33Point, Part D claim volume, percentile in specialty: 63 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 47Point, Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 90Point, Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 40Point, Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 0Point, Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 83Point, Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 37Point, Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 38Point, Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 47Point, Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 20Point, Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 72Point, Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 82Point, Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 87Point, Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 67Point, Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 15Point, Part D claim volume, percentile in specialty: 30 · MIPS quality, percentile: 3Point, Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 77Point, Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 53Point, Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 17Point, Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 45Point, Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 28Point, Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 88Point, Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 52Point, Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 70Point, Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 53Point, Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 10Point, Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 58Point, Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 10Point, Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 5Point, Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 43Point, Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 85Point, Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 20Point, Part D claim volume, percentile in specialty: 97 · MIPS quality, percentile: 18Point, Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 32Point, Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 65Point, Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 62Point, Part D claim volume, percentile in specialty: 12 · MIPS quality, percentile: 27Point, Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 68Megan Baumgart, M.D., Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 18
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Megan Baumgart, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

✓
Board certification likely (heuristic, not verified)

Megan Baumgart, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Megan Baumgart, M.D.?

Below national average

NPI registry status

Active

Issued 05/31/2007

NPI 1881896157

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,530 US NPIs in this specialty

Medicare Part D claims

359 59% vs specialty avg

2024 prescription claims

Specialty avg: 885

MIPS final score

76.8/100 6.7 pts vs avg

Above neutral band

vs 83.5 national avg

Specialty distribution in New York

How Hematology & Oncology Physician compares to other specialties among New York providers

New York providers
Student in an Organized Heal…8%Registered Nurse5.2%Clinical Social Worker4.9%Social Worker4.5%Speech-Language Pathologist4.5%Licensed Practical Nurse4.3%Hematology & Oncology Physic…0.2%
Largest specialties in New York (% of in-state providers)

Medicare quality performance, MIPS

Megan Baumgart, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Below national average
MIPS Final Score
76.8/100
vs 83.5 national avg · 2023 performance year
0%100%National avg84%76.8%
MIPS final score (Hematology & Oncology Physician) - 76.8/100 vs national avg 83.5
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

601 ELMWOOD AVE
Rochester, NY 14642
(585) 275-5863

Provider Details

NPI 1881896157
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Female
NPI Issued 05/31/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

76.8466
Final Score
Measured-score avg: 83.5
68.2024
Quality
42.684
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where Megan Baumgart, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Hematology Clinical Group
Rochester, NY
University OF Rochester
Rochester, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context - New York NYSBPMC 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Megan Baumgart, M.D.. To verify Megan Baumgart, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

Megan Baumgart, M.D. - brand share 14.0%
Hematology & Oncology Physician average

14% brand-name claims vs 86% generic, on 359 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

359
Total Claims
$502K
Total Drug Cost
107
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
378.567
Total Day Supply
6,734
Brand vs Generic
14% brand / 86% generic
Brand Drug Cost
$497K
Generic Drug Cost
$5K
Opioid Claims
35 (9.7% rate)
Antibiotic Claims
25

Patient Demographics

Average Patient Age
73.7 years
Avg HCC Risk Score
2.78
Gender Split
53% female / 47% male
Age Distribution
<65: 11, 65-74: 46, 75-84: 39, 85+: 11

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Megan Baumgart, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Prochlorperazine Maleate
 63
Ondansetron Hcl
 51
Levothyroxine Sodium
 32
Oxycodone Hcl
 21
Dexamethasone
 19
Gabapentin
 19
Prednisone
 13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

More Hematology & Oncology Physician in NY → All providers in New York → Compare specialties →

Hematology & Oncology Physician Overview

How Megan Baumgart, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider

Megan Baumgart, M.D.'s 359 claims are below the specialty average of 885.

Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Baumgart, both outside New York so the neighborhoods are not geographic containment.

Similar MIPS final score

Nearest same-specialty clinicians by CMS MIPS final score (76.8 here).

Anne Hutchison 76.8 SC Peter Van Veldhuizen 76.8 MI Srinivasu Chamarthy 76.8 OH Sana Jeffreys 76.8 OH

Same NPPES enumeration year (2007)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Hao Wang Boston, MA Timothy Kristedja Santa Monica, CA Rahim Remtulla Coraopolis, PA Andrew Moore Cape Girardeau, MO

Nearby Hematology & Oncology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Baumgart.

One of 999 Hematology & Oncology Physician providers enrolled in New York, 5 are shown here.

Dr. Anum Aamir
M.D
Astoria, NY
Dr. Robert Abderhalden
MD
Painted Post, NY
Dr. Mohammad Maher Abdul Hay
MD
New York, NY
Dr. George Abraham
MD
Rochester, NY
Dr. Avram Abramowitz
M.D.
Fresh Meadows, NY

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Megan Baumgart, M.D.'s specialty? ▼
Megan Baumgart, M.D. specializes in Hematology & Oncology Physician and practices in Rochester, New York. Credentials: M.D..
How much does Megan Baumgart, M.D. prescribe under Medicare Part D? ▼
In 2024, Megan Baumgart, M.D. wrote 359 Medicare Part D claims totaling $502K in drug costs for 107 beneficiaries.
What is Megan Baumgart, M.D.'s Medicare quality score? ▼
Megan Baumgart, M.D. has a CMS MIPS Final Score of 76.8/100 (Quality: 68.2, Cost: 42.7). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Megan Baumgart, M.D. located? ▼
Megan Baumgart, M.D. is located at 601 ELMWOOD AVE, Rochester, NY, 14642. Phone: (585) 275-5863.
What is Megan Baumgart, M.D.'s NPI number? ▼
Megan Baumgart, M.D.'s National Provider Identifier (NPI) is 1881896157, issued on 05/31/2007.
Does Megan Baumgart, M.D. prescribe more brand-name or generic drugs? ▼
Megan Baumgart, M.D.'s prescribing is 14% brand-name and 86% generic drugs by claim count, with $497K in brand drug costs.
Does Megan Baumgart, M.D. prescribe opioids? ▼
Yes, Megan Baumgart, M.D. had 35 opioid claims in 2024 with an opioid prescribing rate of 9.7%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does Megan Baumgart, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Megan Baumgart, M.D.'s most frequently prescribed drugs include Prochlorperazine Maleate, Ondansetron Hcl, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Megan Baumgart, M.D. accept Medicare? ▼
Megan Baumgart, M.D. appears in CMS Medicare data with 359 Part D claims and 107 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Megan Baumgart, M.D.'s credentials? ▼
Megan Baumgart, M.D.'s NPI is 1881896157 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the editorial process.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.